NRM among study subjects with and without TMA at 1 year after HSCT. Gray’s competing risk method was used to obtain the cumulative incidence of NRM. The 1-year NRM was 43.6% ± 8% in subjects with TMA and 7.8% ± 3.8% in HSCT subjects without TMA (P < .0001).